Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
immucin (1 trial)
muc-1 peptide vaccine (1 trial)
sargramostim (leukine) (1 trial)
Multiple Myeloma (Phase 2)
Trials (2 total)
Trial APIs (3 total)